ENGLEWOOD, Colo. - Gevo , Inc. (NASDAQ: NASDAQ:GEVO) and Axens have announced a strategic alliance aimed at propelling the ...

Gevo, Inc. ("Gevo" or the "Company") has filed a petition in ... For more information, read the company's full 8-K submission here. The above analysis is intended for educational purposes only and was ...

Investors in the United States and abroad are girding themselves for a turbulent week amid a looming tariff war.

Gevo , Inc. (NASDAQ:GEVO), currently trading at $1.86 with a market capitalization of $430 million, retained a positive outlook from H.C. Wainwright, with analyst Amit Dayal reiterating a Buy rating ...

As U.S. markets respond positively to recent developments in tariffs and corporate earnings, investors are exploring various opportunities across the financial landscape. Penny stocks, often ...

Gevo, Inc. (NASDAQ: GEVO) has completed the acquisition of Red Trail Energy, LLC's ethanol production plant, carbon capture ...

It offers customizable dashboards for better strategy planning and integrates various data sources for comprehensive analysis. Alpha Research provides in-depth analysis of stocks for investors and ...

ENGLEWOOD, Colo., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Verity Holdings, LLC (“Verity”), a subsidiary of Gevo, Inc. (NASDAQ: GEVO), and Landus are pleased to announce a new agreement aimed at ...

Phase Ib study of gevokizumab (GEVO) in combination with standard-of-care (SoC) anticancer therapies in patients (pts) with metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer ...